| Lynn Marie Herklotz, OTR | |
|
17351 Drake St, Broomfield, CO 80023-5205 | |
| (303) 908-0500 | |
| (720) 465-9320 |
| Full Name | Lynn Marie Herklotz |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 36 Years |
| Location | 17351 Drake St, Broomfield, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164172318 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 1662 (Colorado) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kind Rehabilitation Llc | 9739421967 | 6 |
News Archive
A headache is a painful sensation in any part of the head and can have a multitude of causes that are not necessarily due to underlying illness. They result from signals interacting among the brain, surrounding nerves, and blood vessels.
Amneal Pharmaceuticals is pleased to announce that it has received U.S. FDA approval to manufacture Nizatidine Oral Solution in the 15 mg/mL strength effective November 18, 2009. It is an AA-rated, therapeutically equivalent alternative to Axid® Oral Solution (a licensed trademark of Braintree Labs). Nizatidine Oral Solution is the first available generic in oral solution form and marks Amneal's fourth liquid approval.
An annual global event, Bone and Joint National Action Week is held October 12-20 with activities focused on disorders including arthritis, back pain, osteoporosis, and the effects of childhood obesity on the musculoskeletal system. Events and projects organized worldwide are designed to raise awareness of prevention, disease management and treatments. In the United States, the U.S. Bone and Joint Decade represents the global initiative.
Colorectal cancer is a malignant neoplasm affecting the large bowel and the rectum mainly after the 5th decade of life and representing the second cause of death for cancer in western countries (the third in women). In about 15-20% of patients there is an inherited predisposition.
Patterson Companies, Inc. today reported consolidated sales of $812,762,000 for the fourth quarter of fiscal 2010 ended April 24, an increase of 4% from $779,884,000 in the year-earlier quarter. Internal growth accounted for 1% of the fourth quarter sales increase, with acquisitions and foreign currency adjustments accounting for the balance.
› Verified 9 days ago
| Provider Name | Kind Rehabilitation Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1477016350 PECOS PAC ID: 9739421967 Enrollment ID: O20190508001561 |
News Archive
A headache is a painful sensation in any part of the head and can have a multitude of causes that are not necessarily due to underlying illness. They result from signals interacting among the brain, surrounding nerves, and blood vessels.
Amneal Pharmaceuticals is pleased to announce that it has received U.S. FDA approval to manufacture Nizatidine Oral Solution in the 15 mg/mL strength effective November 18, 2009. It is an AA-rated, therapeutically equivalent alternative to Axid® Oral Solution (a licensed trademark of Braintree Labs). Nizatidine Oral Solution is the first available generic in oral solution form and marks Amneal's fourth liquid approval.
An annual global event, Bone and Joint National Action Week is held October 12-20 with activities focused on disorders including arthritis, back pain, osteoporosis, and the effects of childhood obesity on the musculoskeletal system. Events and projects organized worldwide are designed to raise awareness of prevention, disease management and treatments. In the United States, the U.S. Bone and Joint Decade represents the global initiative.
Colorectal cancer is a malignant neoplasm affecting the large bowel and the rectum mainly after the 5th decade of life and representing the second cause of death for cancer in western countries (the third in women). In about 15-20% of patients there is an inherited predisposition.
Patterson Companies, Inc. today reported consolidated sales of $812,762,000 for the fourth quarter of fiscal 2010 ended April 24, an increase of 4% from $779,884,000 in the year-earlier quarter. Internal growth accounted for 1% of the fourth quarter sales increase, with acquisitions and foreign currency adjustments accounting for the balance.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lynn Marie Herklotz, OTR 715 Merry Ln, Boulder, CO 80303-9712 Ph: (303) 931-3469 | Lynn Marie Herklotz, OTR 17351 Drake St, Broomfield, CO 80023-5205 Ph: (303) 908-0500 |
News Archive
A headache is a painful sensation in any part of the head and can have a multitude of causes that are not necessarily due to underlying illness. They result from signals interacting among the brain, surrounding nerves, and blood vessels.
Amneal Pharmaceuticals is pleased to announce that it has received U.S. FDA approval to manufacture Nizatidine Oral Solution in the 15 mg/mL strength effective November 18, 2009. It is an AA-rated, therapeutically equivalent alternative to Axid® Oral Solution (a licensed trademark of Braintree Labs). Nizatidine Oral Solution is the first available generic in oral solution form and marks Amneal's fourth liquid approval.
An annual global event, Bone and Joint National Action Week is held October 12-20 with activities focused on disorders including arthritis, back pain, osteoporosis, and the effects of childhood obesity on the musculoskeletal system. Events and projects organized worldwide are designed to raise awareness of prevention, disease management and treatments. In the United States, the U.S. Bone and Joint Decade represents the global initiative.
Colorectal cancer is a malignant neoplasm affecting the large bowel and the rectum mainly after the 5th decade of life and representing the second cause of death for cancer in western countries (the third in women). In about 15-20% of patients there is an inherited predisposition.
Patterson Companies, Inc. today reported consolidated sales of $812,762,000 for the fourth quarter of fiscal 2010 ended April 24, an increase of 4% from $779,884,000 in the year-earlier quarter. Internal growth accounted for 1% of the fourth quarter sales increase, with acquisitions and foreign currency adjustments accounting for the balance.
› Verified 9 days ago
Lauren Kaye Braaten, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8401 Arista Pl, Broomfield, CO 80021 Phone: 720-777-1330 | |
Erica Applegate, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8401 Arista Pl, Broomfield, CO 80021 Phone: 720-777-9183 | |
Ryan Edward Burns, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3305 W 144th Ave Unit 200, Broomfield, CO 80023 Phone: 303-284-6569 | |
Patrice S Lensmire Gauthier, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 12970 Sheridan Blvd, Broomfield, CO 80020 Phone: 303-785-5800 | |
Erica R Mercer, OTR Occupational Therapist Medicare: Medicare Enrolled Practice Location: 12975 Sheridan Blvd, Broomfield, CO 80020 Phone: 303-785-5800 | |
Northbrook Hand Therapy, Inc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 80 Garden Ctr, Bldg A, Ste 104, Broomfield, CO 80020 Phone: 720-887-3637 Fax: 720-887-3634 | |
Katherine Krumm Erley, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1145 E 13th Ave, Broomfield, CO 80020 Phone: 303-466-6308 |